Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together
Biotech

BMS inks $15B deal to bag Hengrui assets, tap China’s R&D speed

BMS formed a broad partnership with Hengrui, paying $600 million upfront to advance 13 early-stage programs from across the two companies’ pipelines.
Nick Paul Taylor May 12, 2026 1:56am
Sketch of lungs

Enterprise posts CF win, succeeding where Big Pharma stumbled

May 12, 2026 4:00am
syneos-herov2-04302026png

MRD as a Decision Engine: Rethinking Oncology Trial Design

Brought to you by Syneos Health
sale sold deal

Novo salvages happy ending for scrapped Parkinson’s therapy

May 11, 2026 8:30am
Three blocks displaying from left to right a person a handshake and another person

Boehringer makes €407M bet on Immunitas’ inflammatory asset

May 12, 2026 9:57am
Palm tree branches bending as storm clouds approach

AstraZeneca’s $800M bet undermined by immunogenicity in phase 3

May 12, 2026 9:28am
More News

Bayer scraps ph.1-stage hypertension, neuropathic pain drugs

May 12, 2026 5:07am
Fierce Pharma

Daiichi Sankyo targets global top 5 oncology rank by 2035

May 11, 2026 10:22am

Inhibrx’s OX40-Keytruda combo shows promise in early ph. 2 data

May 11, 2026 10:06am

Amgen-backed quantum computing firm plans IPO

May 10, 2026 8:25am